Loading…
Protecting America in the War on Terror Act of 2005
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
87pct
72d open
vs 4,105 other S bills in the 109th — cohort avg 35d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (16)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Issues relating to support of Office of Women's Health and Public Education Initiatives Childhood immunizations Dietary supplement issues FDA reform issues S.3 Protecting America in the War on Terror H.R. 650 Vaccines Act of 2005 H.R. 2863 Department of Defense Appropriations Act of 2006 Medicare reimbursement for certain drugs Importation Bioterrorism Direct to consumer advertising S.334 Pharmaceutical Market Access and Drug Safety Act of 2005 Implementation issues concerning P.L. 108-173 - The Medicare Prescription Drug, Improvement and Modernization Act of 2003 Issues concerning Medicaid in the Concurrent Resolution on the Budget - Fiscal Year 2006 Medical coverage of self-injective biologicals Issues related to vaccine injury compensation program Follow developments within the Bush Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies Issues relating to Medicaid reimbursement for drugs/biologics in Title VI of S.1932-the Deficit Reduction Act of 2005 Pandemic Influenza S.3678 S. Con. Res 83, "Concurrent Resolution on the Budget for Fiscal Year 2007,: issues relating to amending the Medicare Prescription Drug and Modernization Act of 2003 (P.L.108-173) to authorize the Secretary of HHS to negotiate drug prices for the Part D Medicare prescription drug benefit. H.R. 5384, "Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act of 2007," issues related to the importation of prescription drugs. Issues related to vaccine injury compensation program S.843 - The Combating Autism Act of 2005 H.R. 4939 - Supplemental Appropriations H.R. 5441 - FY 2007 Homeland Security Appropriations Drug Compounding H.R. 5122, S.2767 - Department of Defense Authorizations S.3807 - Enhancing Drug Safety and Innovation Act of 2006 Alzheimer's care HR 5211; S.2767 - Department of Defense Authorizations H.R. 5384 - "Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act of 2007," issues related to the importation of prescription drugs; issues related to the Vaccine Injury Compensation Program Issues related to hormone therapy and the use of HT and BHRT products. Vaccine Injury Compensation Program Follow developments within the Bush Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies
Client expense: $1,986,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Security Council (NSC), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2006 · year_end · Pharmacy
federal drug approval process for generic drugs and appropriated funding (H.R. 376); revision of BioShield provisions of S.3; development of a biogeneric drug approval framework; procedures for drug approval harmonization in prospective trade agreements; implementation of the Medicare Prescription Drug improvement and Modernization Act of 2003 (P.L. 108-391). Issues affecting pharmaeuticals, including: Settlements legislation, S.3582; opposition to legislation proposing patent filing deadline extensions; authorized generics (H.R. 5384); patent reform legislation (H.R. 2795 and S.3818); FDA reform and regulation, and the
Client expense: Not reported · Firm income: $100,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2006 · year_end · Copyright/Patent/Trademark
H.R. 2795 Patent Reform Act of 2005. Various biodefense and vaccine and drug development bills including S.3, S. 975, S. 2564, S. 1873, and S. 3678.
Client expense: $440,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2006 · year_end · Health Issues
Flu vaccine, specifically CDC recommendations S.3673,Pandemic and All Hazards Preparedeness Act of 2005 - provisions relating to pandemic vaccine development S.3, Protecting Americans in the war on Terror Act of 2005 - provisions dealing with vaccines S.1873,Biodefense and Pandemic Vaccine and Drug Development Act of 2005 - provisions relating to pandemic vaccine development
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2006 · year_end · Disaster Planning/Emergencies
S. 3 - Protecting America in the War on Terror Act of 2005; S.2564/H.R. 5533 - BioDefense and Pandemic Vaccine and Drug Development Act of 2006; S. 1873 - BioDefence and Pandemic Vaccine and Drug Development Act of 2005; S. 3678 Pandemic and ALL-Hazards Preparedness Act
Client expense: $1,040,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
| Republican |
| SC |
| Michael DeWine | Republican | OH |
| Mitch McConnell | Republican | KY |
| Richard Santorum | Republican | PA |
| William Frist | Republican | TN |
2006 · year_end · Health Issues
HR 5115-U.S Healthcare Technologies Competitiveness Act of 2006 (Bill to modernize the tax treatment as related to medical devices and biomedical research corporations) HR 4388-Tax Revision Act of 2005 (Bills to amend the Internal Revenue Code of 1986 to extend certain expiring provisions) HR 4297-Tax Relief Extension Reconciliation Act of 2005 (Bill to extend credit for increasing research activities) HR 4845-Innovation and Competitiveness Act HR 1736/S 627-Investment in America Act of 2005 (Bills to make permanent the tax credit for increasing research activities) S 978-Healthcare Tax Relief for the Uninsured Act of 2005 HR 1872-Health Coverage for the Uninsured Act of 2005 (Bills to provide tax incentives for the purchase of quality health care, and for other purposes) HR 5-Help Efficient, Accessible, Low-Cost, Timely Healthcare (HEALTH) Act of 2005 (Bill to provide improved medical care by reducing the excessive burden the liability system places on the health care delivery system) HR 6406-The Tax Relief and Health Care Act of 2006 (Bill to improve temporarily certain rates of duty and make other technical amendments to the trade laws, and to extend certain trade preference programs) S Cong Res 67/H Cong Res 311-Concurrent resolution urging Japan to honor its commitments under the 1986 Market-Oriented Sector-Selective (MOSS) Agreement on Medical Equipment and for other purposes (Bill to reduce regulatory barriers to the approval and adoption of new medical technologies) S 2467-United States Trade Enhancement Act of 2006 (Congressional resolutions on trade enforcement efforts as relates to trade with China) S 295-To authorize appropriate action if the negotiations with the People’s Republic of China’s undervalued currency are not successful) (Bill to impose an additional duty of 27.5% on Chinese imports) HR 3004-Currency Harmonization Initiative through Neutralizing Action Act of 2005 (Bill to impose additional tariffs on Chinese imports on the basis of the rate of manipulation by that country of the rate of exchange between the Chinese currency and the U.S dollar) HR 3283/S 1421-United States Trade Rights Enforcement Act (Bills to enhance resources to enforce U.S trade rights) HR 4157-Health Information Technology Promotion Act of 2005 (Bill to provide for establishment of uniform confidentiality and security standards with respect to individually identifiable patient health information) S 1355-Better Healthcare Through Information Technology Act S 1418-Wired for Health Care Quality Act (Bills to enhance the adoption of health information technology and to improve the quality and reduce the cost of healthcare in the United States) S 1952-Critical Access to Health Information Technology Act of 2005 (Bill to provide for grants to states to increase access to health care in rural areas by improving health information technology) S 1223-Information Technology for Health Care Quality and Improvement Act (Bill to improve the quality and efficiency of health care delivery through improvements in health care information technology) S 1262-Health Technology to Enhance Quality Act of 2005 (Bill to reduce healthcare costs, improve efficiency and healthcare quality through the development of a nation-wide interoperable health information technology system) S 2480-Contact Lens Consumer Protection Act (Bill to amend the Fairness to Contact Lens Consumers Act with respect to the availability of contact lenses) HR 6111-Tax Relief and Health Care Act of 2006 (President Bush signed into Public Law # 109-432 on 12/20/2006) HR 5975-Prescription Drug Comparative Effectiveness Act of 2006 (Bill to require the Agency for Healthcare Research and Quality, in consultation with NIH Director, to conduct research to develop valid scientific evidence regarding clinical effectiveness, outcomes, and appropriateness as relates to medical devices and procedures and for other purposes) S 4098-Pediatric Medical Devices and Safety Improvement Act of 2006 (Bill to improve the process for development of needed pediatric medical devices) S 3778-Small Business Reauthorization and Improvements Act of 2006 HR 5352-Small Business Reauthorization Act of 2006 (Bills to reauthorize programs to assist small business concerns) S 1263-Save America’s Biotechnology Innovative Research Act of 2005 HR 2943-Save Biotechnology Innovative Research Act of 2005 (Bills to establish eligibility requirements for business concerns to receive awards under the Small Business Innovative Research program) S 3678-Pandemic and All Hazards Preparedness Act (Bill with respect to public health security and all-hazards preparedness and response, and for other purposes) HR2863-Division E – Public Readiness and Emergency Preparedness Act (Division E provisions of the bill as relates to targeted liability for pandemic and epidemic products and security countermeasures) S 2564/HR 5533-Biodefense and Pandemic Vaccine and Drug Development Act of 2006 S 1873-Biodefense and Pandemic Vaccine and Drug Development Act of 2005 (Bills to prepare and strengthen the development of countermeasures or pandemic or epidemic products against deliberate, accidental, and natural outbreaks of illness) S-1880-National Biodefense and Pandemic Preparedness Act of 2005 (Bill to enhance biodefense and pandemic preparedness activities) S 2792-Emergency Preparedness and Response Security, Accountability, and Flexibility Enhancement Act (SAFE Act) (Bill to revise provisions relating to bioterrorism and other public health emergencies preparedness grants including development of measurable critical benchmarks and performance standards) S 3-Protecting American in the War on Terror Act of 2005 (Bill sets provisions concerning bioterrorism preparedness and defense as pertaining to medical devices and for other purposes) S 975-The Project Bioshield II Act of 2005 (Bill to provide incentives to increase research by private sector entities to develop medial countermeasures to prevent, detect, identify, contain, and treat illnesses, including those associated with biological, chemical, nuclear, or radiological weapons attack or an infectious disease outbreak) S 22/S23-Malpractice Liability Reform Bill (a.k.a. Medical Care Access Protection Act of 2006, MCAP Act) (Bills setting forth provisions regulating lawsuits for health care liability claims related to the provision of health care services) HR 2090- Food and Drug Administration Improvement Act of 2005 (Bill related to FDA Advisory panels) S. 3807-Enhancing Drug Safety and Innovation Act of 2006 (Draft bill to improve oversight as related to drugs includes medical devices in some provisions)
Client expense: $1,404,102 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2006 · year_end · Retirement
S 222, S 873, S 581, S 345, S 18, S 877, S 1074, S 747, S 334, S 239, S 109, S 184, S 3, S 2493, S 2328, S 2307, S 1307, S 991 HR 918, HR 752, HR 2664, HR 2774, HR 2948, Hr 328, Hr 2427, H Con Res 95, HR 2830, HR 3045
Client expense: Not reported · Firm income: $33,750
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2006 · year_end · Trade (domestic/foreign)
S 222, S 873, S 581, S 345, S 18, S 877, S 1074, S 747, S 334, S 239, S 109, S 184, S 3, S 2493, S 2328, S 2307, S 1307, S 991 HR 918, HR 752, HR 2664, HR 2774, HR 2948, Hr 328, Hr 2427, H Con Res 95, HR 2830, HR 3045
Client expense: Not reported · Firm income: $33,750
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2006 · year_end · Pharmacy
S 222, S 873, S 581, S 345, S 18, S 877, S 1074, S 747, S 334, S 239, S 109, S 184, S 3, S 2493, S 2328, S 2307, S 1307, S 991 HR 918, HR 752, HR 2664, HR 2774, HR 2948, Hr 328, Hr 2427, H Con Res 95, HR 2830, HR 3045
Client expense: Not reported · Firm income: $33,750
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2006 · year_end · Budget/Appropriations
S 222, S 873, S 581, S 345, S 18, S 877, S 1074, S 747, S 334, S 239, S 109, S 184, S 3, S 2493, S 2328, S 2307, S 1307, S 991 HR 918, HR 752, HR 2664, HR 2774, HR 2948, Hr 328, Hr 2427, H Con Res 95, HR 2830, HR 3045
Client expense: Not reported · Firm income: $33,750
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2006 · year_end · Taxation/Internal Revenue Code
S 222, S 873, S 581, S 345, S 18, S 877, S 1074, S 747, S 334, S 239, S 109, S 184, S 3, S 2493, S 2328, S 2307, S 1307, S 991 HR 918, HR 752, HR 2664, HR 2774, HR 2948, Hr 328, Hr 2427, H Con Res 95, HR 2830, HR 3045
Client expense: Not reported · Firm income: $33,750
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2006 · year_end · Health Issues
S 222, S 873, S 581, S 345, S 18, S 877, S 1074, S 747, S 334, S 239, S 109, S 184, S 3, S 2493, S 2328, S 2307, S 1307, S 991 HR 918, HR 752, HR 2664, HR 2774, HR 2948, Hr 328, Hr 2427, H Con Res 95, HR 2830, HR 3045
Client expense: Not reported · Firm income: $33,750
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2006 · year_end · Homeland Security
S. 975: A bill to provide incentives to increase research by private sector entities to develop medical counter measures to prevent, detect, identify, contain, and treat illnesses, including those associated with biological, chemical, nuclear, or radiological weapons attack or an infectious disease outbreak, and for pandemic preparedness provisions. "S. 1873: A bill to prepare and strengthen the biodefenses of the United States against deliberate, accidental, and natural outbreaks of illness, and for other purposes. Lobbied for a vaccine liability and compensation program for Pandemic Vaccines. H.R. 1815, S. 1042: National Defense Authorizations Act for Fiscal Year 2006. Lobbied for a vaccine liability and compensation program for Pandemic Vaccines. H.R. 2601: To authorize appropriations for the Department of State for Fiscal Years 2006 and 2007. Lobbied for sufficient funding for bioterrorist medical counter measures. S. 3: A bill to strengthen and protect America in the war on terror. Lobbied for incentives to manufacture biomedical counter measures.
Client expense: Not reported · Firm income: $100,000
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2006 · mid_year · Health Issues
S. 3, National Surveillance Issues in Bioterrorism legislation S. 2792, Emergency Preparedness and Response Security, Accountability, and Flexibility Enhancement Act, National Surveillance Issues S. 3678, Pandemic and All-Hazards Preparedness Act, National Surveillance Issues, Epidemiologic training S. 2506, Healthy Places Act, support whole measure H.R. 5088, Healthy Places Act, support whole measure
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2006 · mid_year · Pharmacy
1. H.R. 4241, House Deficit Reduction Act of 2005 2. S. 1932, Senate Deficit Reduction Act of 2005 3. H.R. 3199, USA Patriot Act Reauthorization 4. S. 1716, Emergency Health Care Relief Act of 2005 5. H.R. 4297, the Tax Relief Extension Reconciliation Act 6. H.R. 3010, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2006 7. S. 544, the Patient Safety and Quality Improvement Act of 2005 8. H.R. 3205, the Patient Safety and Quality Improvement Act of 2005 9. H.R. 1132, the National All Schedules Prescription Electronic Reporting Act of 2005 10. S. 518, the National All Schedules Prescription Electronic Reporting Act of 2005 11. S. 1392, the Federal Trade Commission Reauthorization Act of 2005 12. S. 334, the Pharmaceutical Market Access and Drug Safety Act 13. H.R. 700, the Pharmaceutical Market Access and Drug Safety Act of 2005 14. S. 309, the Pharmaceutical Market Access Act 15. H.R. 328, the Pharmaceutical Market Access Act 16. S.3, the Protecting America in the War on Terror Act of 2005 17. H.R. 3010, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2006 18. H.R. 1808, the Safe Online Drug Act of 2005 19. S. 399, the Ryan Haight Internet Pharmacy Consumer Protection Act of 2005 20. H.R. 840, the Ryan Haight Internet Pharmacy Consumer Protection Act of 2005 21. S. 14, the Fair Wage, Competition, and Investment Act of 2005 22. S. 534, the Health Efficient, Accessible, Low-Cost, Timely Healthcare Act of 2005 23. H.R. 5, the Health Efficient, Accessible, Low-Cost, Timely Healthcare Act of 2005 24. H.R. 1669, the Pharmacy Benefit Manager Transparency Act of 2005 25. H.R. 1671, the Community Pharmacy Fairness Act of 2005 26. S. 103, the Combat Meth Act of 2005 27. H.R. 314, the Combat Meth Act of 2005 28. S. 102, the Exile Meth Act 29. H.R. 313, the Exile Meth Act 30. H.R. 3889, Meth Epidemic Elimination Act 31. H.R. 1446, the Methamphetamine Abuse Prevention Act of 2005 32. H.R. 1055, the Comprehensive Methamphetamine Response Act 33. H.R. 1056, the Methamphetamine Precursor Control Act of 2005 34. H.R. 1378, the Ephedrine Alkaloids Regulation Act of 2005 35. H.R. 2829, the Office of National Drug Control Policy Reauthorization Act of 2005 36. H.R. 3617, the Medicare Value-Based Purchasing for Physicians' Services Act of 2005 37. S. 1356, the Medicare Value Purchasing Act of 2005 38. S. 1408, the Identity Theft Protection Act 39. S. 1332, the Personal Data Privacy and Security Act of 2005 40. S. 930, the Food and Drug Administration Safety Act of 2005 41. H.R. 1652, the Access to Legal Pharmaceuticals Act 42. S. 809, the Access to Legal Pharmaceuticals Act 43. H.R. 1539, a bill to amend the Public Health Service Act with respect to the responsibilities of a pharmacy when a pharmacist employed by the pharmacy refuses to fill a valid prescription for a drug 44. S. 338, the Bipartisan Commission on Medicaid Act of 2005 45. H.R. 985, the Bipartisan Commission on Medicaid Act of 2005 46. S. Con.Res.18, Budget FY2006 Appropriations resolution 47. H. Con.Res.95, 18, Budget FY2006 Appropriations resolution 48. S. 1262, the Health Technology to Enhance Quality Act of 2005 49. S.3678, the Pandemic and All-Hazards Preparedness Act 50. S.2564, the Biodefense and Pandemic Vaccine and Drug Development Act of 2006 51. H.R. 5533, the Biodefense and Pandemic Vaccine and Drug Development Act 52. H.R. 5262, Tax Free Savings Act of 2006 53. S. 3546, the Dietary Supplement and Nonprescription Drug Consumer Protection Act 54. H.R. 4157, the Health Information Technology Promotion Act of 2005 55. S. 2766, the National Defense Authorization Act for Fiscal Year 2007 56. S.2810, the Medicare Late Enrollment Assistance Act of 2006 57. H.R.5399, the Medicare Drug Benefit Enrollment Fairness Act of 2006 58. H.R. 5182, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2006 59. S. 2563, the Pharmacist Access and Recognition in Medicare (PhARM) Act of 2006 60. S. 2664, the Pharmacy Access Improvement (PhAIm) Act of 2006 61. H.R. 4769, the Prescription Drug Elimination Act of 2006 62. S. 2300, the Lower Prices With Increased Competition and Efficient Development of Drugs Act (the Lower Priced Drugs Act) 63. H.R. 5166 – The Independent Pharmacy Protection Act of 2006 64. S. 2181, the Medicare State Reimbursement Act 65. S. 2183, the Requiring Emergency Pharmaceutical Access for Individual Relief (REPAIR) Act 66. H.R. 4297, the Tax Relief Extension Reconciliation Act 67. H.R. 5384, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2007 68. H.R.5441, the Department of Homeland Security Appropriations Act, 2007 69. S. 2020, Tax Relief Act of 2005
Client expense: $460,000 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Personnel Management (OPM), SENATE, White House Office
2005 · year_end · Health Issues
S. 3, National Surveillance Issues in Bioterrorism legislation
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2005 · year_end · Homeland Security
S. 975: Project BioShield II Act of 2005 S. 3: Protecting America in the War on Terror Act of 2005 S. 1873: The Biodefense and Pandemic Vaccine and Drug Development Act of 2005
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2005 · year_end · Homeland Security
S. 3: A bill to strengthen and protect America in the war on terror. Lobbied for incentives to manufacture biomedical counter measures. S. 975: A bill to provide incentives to increase research by private sector entities to develop medical counter measures to prevent, detect, identify, contain, and treat illnesses, including those associated with biological, chemical, nuclear, or radiological weapons attack or an infectious disease outbreak, and for pandemic preparedness provisions.S. 1873: A bill to prepare and strengthen the biodefenses of the United States against deliberate, accidental, and natural outbreaks of illness, and for other purposes. Lobbied for a vaccine liability and compensation program for Pandemic Vaccines. H.R. 1815, S. 1042: National Defense Authorizations Act for Fiscal Year 2006. Lobbied for a vaccine liability and compensation program for Pandemic Vaccines. H.R. 2601: To authorize appropriations for the Department of State for Fiscal Years 2006 and 2007. Lobbied for sufficient funding for bioterrorist medical counter measures.
Client expense: Not reported · Firm income: $100,000
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2005 · year_end · Health Issues
S.3 "Bio-preparedness Act" S.1262 "Health Technology to Enhance Quality Act" S.16 "Affordable Health Care Act" S.109 "Pharmaceutical Market Access Act of 2005" S.184 "Safe Importation of Medical Products and Other Rx Therapies Act of 2005" S.518 "National All Schedules Prescription Electronic Reporting Act of 2005"S.975 "Project BioSheild II Act of 2005" S1418 "Wired for Health Care Quality Act" HR.2234 "21 Century Health Information Act"
Client expense: Not reported · Firm income: $75,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2005 · year_end · Health Issues
S.3 "Biopreparedness Act" S.16 ŽAffordable Health Care ActŽ S.306 Genetic Information Nondiscrimination ActŽ S.1262 ŽHealth Technology to Enhance Quality ActŽ S.1337 Fair and Reliable Medical Justice ActŽ S.1355 Health Information Technology Quality Improvement ActŽHR.2234 21 Century Health Information ActŽ
Client expense: Not reported · Firm income: $105,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2005 · year_end · Health Issues
S.3, Protecting American in the War on Terror Act of 2005 - provisions dealing with vaccines Flu vaccine, specifically CDC recommendations
Client expense: Not reported · Firm income: $100,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2005 · mid_year · Defense
S.3, S. 975, BioShield II legislation. Monitor legislation regarding biodefense vaccines and therapeutics.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2005 · mid_year · Medical/Disease Research/Clinical Labs
S. 3, S. 975, BioShield II legislation. Monitor legislation regarding biodefense vaccines and therapeutics.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2005 · mid_year · Health Issues
H.R.3423/S.1420-Medical Device User Fee Stabilization Act of 2005. (Bills related to user fees for medical devices.) H.R. 2090-Food and Drug Administration Improvement Act of 2005 (Bill related to FDA Advisory panels.) H.R.3196/S.470-Fair Access to Clinical Trials (FACT) Act (Bills to expand the scope of information required for the data bank on clinical trials.) S.3-Protecting America in the War on Terror Act of 2005 - Biopreparedness Act of 2005. (Bill sets provisions concerning bioterrorism preparedness and defense as pertaining to medical devices.) S.975-The Project Bioshield II Act of 2005. (Bill to provide incentives to increase research by private sector entities to develop medical countermeasures to prevent, detect, identify, contain, and treat illnesses, including those associated with biological, chemical, nuclear, or radiological weapons attack or an infectious disease outbreak.) H.R.5-Help, Efficient, Accessible, Low-Cost, Timely Healthcare (HEALTH) Act of 2005. (Bill to provide improved medical care by reducing excessive burden the liability system places on the health care delivery system.) S.295-To authorize appropriate action if the negotiations with the People's Republic of Chhina's undervalued currency are not successful. (Bill to impose an additional duty of 27.5% on Chinese imports.) H.R.3004-Currency Harmonization Initiative through Neutralizing Action Act of 2005. (Bill to impose additional tariffs on Chinese imports on the basis of the rate of manipulation by that country of the rate of exchange between the Chinese currency and the U.S. dollar.) H.R.3045/S.1307-Dominican Republic-Central American-United States Free Trade Agreement Implementation Act. (Bills implementing the Central American-Dominican Republic Free Trade Agreenment (CAFTA-DR) into law.) H.R.3283/S.1421-United States Trade Rights Amendments Act (Bill to enhance resources to enforce U.S. trade rights.) S.950-Elimination of Neglected Diseases Act of 2005. (Bill to provide assistance to combat turburculosis, malaria and other infecitous diseases.) S.1223-Information Technology for Health Care Quality and Improvement Act. S.1355-Better Healthcare Through Information Technoogy. (Bills to enhance the adoption of health information technology and to improve the quality and reduce the costs of health care in the United States.) S.1262-Health Technology to Enhance Quality Act of 2005. S.1418-Wired for Health Care Quality Act (Bills to reduce healthcare costs, improve efficiency and healthcare quality through development of a nation-wide interoperable health information technology system.) S.978-Healthcare Tax Relief for the Uninsured Act of 2005. H.R.1872-Health Coverage for the Uninsured Act of 2005. (Bills to provide tax incentives for the purchase of quality health care, and for other purposes.)
Client expense: $2,460,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR)
2005 · mid_year · Health Issues
Bioshield Legislation (S.3, S.975) Comparative Effectiveness Funding (LABOR-HHS FY 2006 Appropriations) Health Information Technology (S.1355, S.1418) Health Savings Accounts Medicare Implementation Issues Value-Based Purchasing (S.1356)
Client expense: $4,060,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Council of Economic Advisers (CEA), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Federal Communications Commission (FCC), Federal Energy Regulatory Commission (FERC), Federal Highway Administration (FHA), Federal Maritime Commission, Federal Railroad Administration, Federal Reserve System, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Aeronautics & Space Administration (NASA), Natl Economic Council (NEC), Natl Highway Traffic Safety Administration (NHTSA), Natl Science Foundation (NSF), Natl Transportation Safety Board (NTSB), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Office of the Vice President of the United States, Pension Benefit Guaranty Corporation (PBGC), SENATE, State, Dept of (DOS), Surface Transportation Board (STB), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2005 · mid_year · Pharmacy
S3 "Protecting America in the War on Terror act of 2005" sections pertaining to drug patent extensions; Medication therapy management programs; Pharmacy Benefit Management in Service Benefit Plan; Clinical Trials
Client expense: $3,100,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, White House Office
2005 · mid_year · Health Issues
S.3 "Biopreparedness Act" S.334 "Pharmaceutical Market Access and Drug Safety Act" S.1262 "Health Technology to Enhance Quality Act" S.1337 "Fair and Reliable Medical Justice Act" S.1355 "Health Information Technology Quality and Improvement Act" S.16 "Affordable Health Care Act" HR.328 "Pharmaceutcial Market Access Act" HR.2234 "21st Century Health Information Act"
Client expense: Not reported · Firm income: $75,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2005 · mid_year · Medical/Disease Research/Clinical Labs
Issues related to vaccines Support S. 3, S.975, S.375, H.R.813 and S. 969 all dealing with pandemic Flu preparedness. Work with Congress to improve each bill. H.R. 3010, Labor HHS Appropriations, insure funding for pandemic Flu preparedness
Client expense: Not reported · Firm income: $100,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2005 · mid_year · Pharmacy
FDA related issues S. 975 and S. 3: BioShield legislation
Client expense: Not reported · Firm income: $100,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office